Stocks

The table gives an overview of all stocks, alphabetically sorted.
 K-Fast Holding B KFASTB 0.00 0.00   
 K2A Knaust & Andersson Fastigh K2AB Dec 13, 2019 139.50 +0.36   
 K2A Knaust & Andersson Fastigh K2APREF Dec 13, 2019 337.00 -0.30   
 KABE Group B KABEB Dec 13, 2019 140.50 -0.35   
 Kakel Max KAKEL Dec 13, 2019 11.60 0.00   
 Kallebäck Property Invest KAPIAB Dec 13, 2019 182.00 0.00   
 Kambi Group KAMBI Dec 13, 2019 174.00 -10.77   
 Kancera KAN Dec 13, 2019 0.51 -0.58   
 Karessa Pharma Holding KARE Dec 13, 2019 3.48 +12.26   
 Karnov Group KAR Dec 13, 2019 50.00 -0.99   
 Karo Pharma KARO Dec 13, 2019 39.26 -0.56   
 Karolinska Development B KDEV Dec 13, 2019 3.34 -4.02   
 Kentima Holding B KENH Dec 13, 2019 1.21 -1.23   
 Kid KIDO Dec 13, 2019 46.50 0.00   
 Kindred Group SDB KINDSDB Dec 13, 2019 55.14 -0.65   
 Kinnevik A KINVA Dec 13, 2019 233.50 -0.43   
 Kinnevik B KINVB Dec 13, 2019 224.30 -0.84   
 Kitron KITO Dec 13, 2019 9.60 0.00   
 Klaria Pharma Holding KLAR Dec 13, 2019 5.20 +1.96   
 Klövern A KLOVA Dec 13, 2019 20.10 +0.75   
 Klövern B KLOVB Dec 13, 2019 20.20 +0.60   
 Klövern Pref KLOVPREF Dec 13, 2019 363.50 0.00   
 Knowit KNOW Dec 13, 2019 204.50 +2.87   
 Kongsberg Automotive ASA KOAO Dec 13, 2019 5.05 0.00   
 Kongsberg Gruppen KOGO Dec 13, 2019 142.00 0.00   
 Kontigo Care KONT Dec 13, 2019 4.08 +2.00   
 Kopparbergs B KOBRB Dec 13, 2019 176.20 +1.26   
 Kopy Goldfields KOPY Dec 13, 2019 0.99 -0.20   
 Kungsleden KLED Dec 13, 2019 93.80 -0.85   
 Kværner KVAERO Dec 13, 2019 11.01 0.00   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK